AFRM vs RLMD · P/E 590, rev $3.22B vs $692.3M cap
Affirm Holdings Inc (AFRM) versus Relmada Therapeutics Inc (RLMD) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
Relmada Therapeutics Inc (RLMD) is a biotechnology company listed on NASDAQ.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
RLMD does not have a complete income-statement cache yet.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. RLMD currently screens at market cap $692.3M.
Not investment advice. Open the AFRM and RLMD stock pages for the full models.
Not investment advice.